The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.

"The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence.

The decision criterion for considering a new sequence as superior to the standard sequence will be based on two measures:

1. The proportion of patients for whom the new sequence was preferred, which must be greater than or equal to 75%;
2. Inter-observer agreement (Cohen's Kappa coefficient), which must be greater than or equal to 0.8; When these two criteria are met, the new sequence will be considered superior to the standard sequence"

Inclusion Criteria:

• Adult patient
• Patient who signed a consent to participate in the study
• Affiliated patient or beneficiary of a social security scheme
• Patient having an MRI scheduled as part of their care pathway
• Absence of prohibition of participation in another research

Exclusion Criteria:

• Patients under guardianship or curators
• Pregnant or breastfeeding patients
• Patients responding to a contraindication to performing an MRI
• Patient under state medical aid (AME)
• Adult patients protected by law